Terms: = Head and neck cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
167 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral cancer Cells.
Yadav AK; Wang S; Shin YM; Jang BC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474118
[TBL] [Abstract] [Full Text] [Related]
3. Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses.
Xiao Y; Xu B; Li X; Ding T; Zhao W; Nie X; Mu J; Xiao Z; Wang Q; Ren Q; Zhang E
Steroids; 2024 May; 205():109393. PubMed ID: 38458369
[TBL] [Abstract] [Full Text] [Related]
4. Exploring the pharmacological mechanisms of Biyan Qingdu Granula in the treatment after nasopharyngeal carcinoma radiotherapy based on UPLC/Q-TOF MS, network pharmacology and molecular docking.
Yi B; Lv F; Zhang N; Lin J; Xu K; Li C; Li P; Zhao M
J Pharm Biomed Anal; 2024 Feb; 239():115830. PubMed ID: 38096633
[TBL] [Abstract] [Full Text] [Related]
5. Using network pharmacological analysis and molecular docking to investigate the mechanism of action of quercetin's suppression of oral cancer.
Dong H; Li M; Chen H; Tian L; Wei W; Wang S; Cheng G; Liu S
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15055-15067. PubMed ID: 37610675
[TBL] [Abstract] [Full Text] [Related]
6. Intensified Adjuvant treatment for High-Risk Resected Cutaneous Angiosarcoma of the head and neck.
El Shatanofy M; Thakkar P; Patel V; Joshi A; Goodman J; Siegel R; Haroun F; Ojong-Ntui M; Goyal S; Bauman J; Rao YJ
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1225-1233. PubMed ID: 37464928
[TBL] [Abstract] [Full Text] [Related]
7. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
8. src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma.
Zhang J; Zhao D; Zhang L; Xiao Y; Wu Q; Wang Y; Chen J; Zhan Q
Sci China Life Sci; 2023 Jun; 66(6):1245-1263. PubMed ID: 36763244
[TBL] [Abstract] [Full Text] [Related]
9. ANXA2 as a novel substrate of FBXW7 promoting esophageal squamous cell carcinoma via ERK phosphorylation.
Li Z; Pan Y; Yao J; Gao Y; Qian Y; Zheng M; Ma S
Biochem Biophys Res Commun; 2023 Mar; 649():93-100. PubMed ID: 36758484
[TBL] [Abstract] [Full Text] [Related]
10. Targeting src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models.
Su L; Chen Y; Huang C; Wu S; Wang X; Zhao X; Xu Q; Sun R; Kong X; Jiang X; Qiu X; Huang X; Wang M; Wong PP
Sci Transl Med; 2023 Jan; 15(678):eabl7895. PubMed ID: 36630483
[TBL] [Abstract] [Full Text] [Related]
11. c-src inhibitor PP2 inhibits head and neck cancer progression through regulation of the epithelial-mesenchymal transition.
Lee S; Park S; Ryu JS; Kang J; Kim I; Son S; Lee BS; Kim CH; Kim YS
Exp Biol Med (Maywood); 2023 Mar; 248(6):492-500. PubMed ID: 36527337
[TBL] [Abstract] [Full Text] [Related]
12. pH-responsive nanoprodrugs combining a src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer.
Zhu SW; Ye M; Ma X; Wu ZZ; Wan SC; Yang SC; Li H; Xu Z; Sun ZJ
Acta Biomater; 2022 Dec; 154():497-509. PubMed ID: 36367476
[TBL] [Abstract] [Full Text] [Related]
13. Latifolin, a Natural Flavonoid, Isolated from the Heartwood of
Yun HM; Park JE; Lee JY; Park KR
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362414
[TBL] [Abstract] [Full Text] [Related]
14. Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma.
Kim JH; Shin WS; Lee SR; Kim S; Choi SY; Lee ST
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293051
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract] [Full Text] [Related]
16. Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating src and EGFR signaling.
Guo J; Chang C; Yang LY; Cai HQ; Chen DX; Zhang Y; Cai Y; Wang JJ; Wei WQ; Hao JJ; Wang MR
Biochem Biophys Res Commun; 2022 Jun; 609():75-83. PubMed ID: 35421632
[TBL] [Abstract] [Full Text] [Related]
17. Recurrent neck myxofibrosarcoma: a case report.
Pagnoni C; Improta L; Alloni R; Mallozzi Santa Maria F; Aprile I; Brunetti B; Greco C; Vincenzi B; Gronchi A; Valeri S
J Med Case Rep; 2021 Oct; 15(1):484. PubMed ID: 34593019
[TBL] [Abstract] [Full Text] [Related]
18. IGF1R and src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK.
Lehman CE; Spencer A; Hall S; Shaw JJP; Wulfkuhle J; Petricoin EF; Bekiranov S; Jameson MJ; Gioeli D
Sci Rep; 2021 May; 11(1):10826. PubMed ID: 34031486
[TBL] [Abstract] [Full Text] [Related]
19. Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated src family kinases as prognostic markers and potential targets.
Bußmann L; Hoffer K; von Bargen CM; Droste C; Lange T; Kemmling J; Schröder-Schwarz J; Vu AT; Akingunsade L; Nollau P; Rangarajan S; de Wijn R; Oetting A; Müller C; Böckelmann LC; Zech HB; Berger JC; Möckelmann N; Busch CJ; Böttcher A; Gatzemeier F; Klinghammer K; Simnica D; Binder M; Struve N; Rieckmann T; Schumacher U; Clauditz TS; Betz CS; Petersen C; Rothkamm K; Münscher A; Kriegs M
Int J Cancer; 2021 Sep; 149(5):1166-1180. PubMed ID: 33890294
[TBL] [Abstract] [Full Text] [Related]
20. Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma.
Solomon D; Abbas M; Feferman Y; Haddad R; Perl G; Kundel Y; Morgenstern S; Menasherov N; Kashtan H
Ann Surg Oncol; 2021 Sep; 28(9):4929-4940. PubMed ID: 33709175
[TBL] [Abstract] [Full Text] [Related]
[Next]
